US EditionPublished • loading... • Updated
Akura Raises Financing for Thrombectomy System and Quantification Software
Summary by Endovascular Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Cardiac Interventions TodayReposted by 
Endovascular Today
Endovascular TodayAkura Raises Financing for Thrombectomy System and Quantification Software
December 1, 2025—Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced it has secured a $53 million first close in Series C financing. The company advised that the funds will be used to support development activities for the Katana thrombectomy system and the NavIQ quantification software; completion of enrollment in the QUADRA-PE clinical trial; and regulatory submissions. The round was led by Qatar Inves…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
